Document Detail


Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failure.
MedLine Citation:
PMID:  21920622     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report a woman presenting with respiratory failure due to a right-sided pleural effusion, lung metastases and lymphangitis carcinomatosis from advanced lung adenocarcinoma in the third trimester of pregnancy, who showed good response to EGFR tyrosine kinase inhibitor.
Authors:
Chee-Hong Lee; Chong-Kin Liam; Yong-Kek Pang; Keong-Tiong Chua; Boon-Khaw Lim; Nai-Lang Lai
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2011-09-13
Journal Detail:
Title:  Lung cancer (Amsterdam, Netherlands)     Volume:  74     ISSN:  1872-8332     ISO Abbreviation:  Lung Cancer     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-10-14     Completed Date:  2012-02-08     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  8800805     Medline TA:  Lung Cancer     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  349-51     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Division of Respiratory Medicine, Department of Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia. ipohchlee@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / drug therapy*,  genetics,  physiopathology,  secondary
Adult
Disease Progression
Female
Humans
Lung Neoplasms / drug therapy*,  genetics,  pathology,  physiopathology
Lymphangitis
Lymphatic Metastasis
Neoplasm Staging
Pleural Effusion, Malignant
Pregnancy
Pregnancy Complications, Neoplastic / drug therapy*,  genetics,  pathology,  physiopathology
Pregnancy Trimester, Third
Quinazolines / administration & dosage*,  pharmacology
Receptor, Epidermal Growth Factor / antagonists & inhibitors,  genetics
Remission Induction
Respiratory Insufficiency
Sequence Deletion / genetics
Term Birth
Chemical
Reg. No./Substance:
0/Quinazolines; EC 2.7.10.1/Receptor, Epidermal Growth Factor; J4T82NDH7E/erlotinib; S65743JHBS/gefitinib

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Urbanization and the utilization of outpatient services under National Health Insurance in Taiwan.
Next Document:  ER? phenotype, estrogen level, and benzo[a]pyrene exposure modulate tumor growth and metabolism of l...